MedPath

Cognitive Behavioural Therapy for Youths With Depressive and Anxiety Symptoms in Hong Kong

Not Applicable
Conditions
Depressive Symptoms
Anxiety Symptoms
Interventions
Behavioral: Cognitive Behavioural Therapy
Registration Number
NCT05078424
Lead Sponsor
The University of Hong Kong
Brief Summary

The proposed study is a randomized controlled trial (RCT) that aims to examine the effectiveness of cognitive behavioural therapy in reducing depressive and anxiety symptoms for youths in Hong Kong. It is to be carried out with 120 youths aged 12 - 24 recruited from a series of community-based LevelMind@JC hubs, funded by the Hong Kong Jockey Club Charities Trust. It is designed to improve the youths' abilities/ skills in handling moods to have better emotional management. A written informed consent will be signed by participants. Researchers will perform cognitive behavioural therapy on youths who agree to join the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
128
Inclusion Criteria
  • LevelMind@JC users with mild to moderate distress level (n=120);
  • have sufficient proficiency in Chinese to understand verbal instructions and give informed consent;
Read More
Exclusion Criteria
  • known diagnosis of intellectual disability
  • organic brain disorder
  • photosensitive epilepsy
  • significant visual, auditory or balance impairment
  • current or previous use of illicit drugs
  • known psychiatric diagnosis (stabilized diagnosis and treatment)
  • receiving any psychosocial treatment for social withdrawal such as CBT or;
  • current or active suicidal ideation or attempts.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBT Treatment groupCognitive Behavioural TherapyThis group receives CBT interventions that aim to improve mental well-being, depressive and anxiety symptoms in young people.
Primary Outcome Measures
NameTimeMethod
Change in depressive levelsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Patient Health Questionnaire-9 (PHQ-9), scores ranging from 0-27 with higher scores representing higher depressive levels hence worse outcome

Change in depressive and anxiety levelsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Depression Anxiety Stress Scales (DASS), scores ranging from 0-42 for each subscale, with higher scores representing worse outcome

Change in anxiety levelsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Generalized Anxiety Stress Scale-7 (GAD-7), scores ranging from 0-21 with higher scores representing higher anxiety levels hence worse outcome

Change in depressive symptomsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Beck Depression Inventory II (BDI-II), scores ranging from 0-63 with higher scores representing severe depressive symptoms hence worse outcome

Change in anxiety symptomsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Beck Anxiety Inventory (BAI), scores ranging from 0-36 with higher scores representing severe anxiety symptoms hence worse outcome

Change in social anxiety levelsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Social Interaction Anxiety Scale (SIAS), scores ranging from 0-80 with higher scores representing higher levels of social anxiety hence worse outcome

Change in distress levelsBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Kessler Psychological Distress Scale (K6), scores ranging from 0-25 with higher scores representing higher distress hence worse outcome

Secondary Outcome Measures
NameTimeMethod
Change in self-harmBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Self-harming behaviour, plans and thoughts, recording as binary response (0=No, 1=Yes)

Change in resilienceBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Connor-Davidson Resilience Scale (CD-RISC), scores ranging from 0-100 with higher scores indicating higher resilience

Change in self-esteemBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Rosenberg Self Esteem Scale (RSE), scores ranging from 0-30 with higher scores indicating higher self-esteem

Change in mindfulnessBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Mindful Attention Awareness Scale (MAAS), scores ranging from 1-6 with higher scores indicating higher mindful awareness

Change in functioningBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Role Functioning Scale (RFS), scores ranging from 1-28 with higher scores representing better functioning

Change in social and occupational functioningBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Social and Occupational Functioning Assessment Scale (SOFAS), scores ranging from 0-100 with higher scores representing better functioning

Change in quality of lifeBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

12-item Short Form Survey (SF-12), scores ranging from 0-100 with higher scores representing better quality of life

Change in future outlookBaseline, after 7 weeks of intervention/wait, and 1 month after post-intervention

Future Outlook Inventory (FOI), scores ranging from 1-70 with higher scores indicating greater degree of future consideration

Trial Locations

Locations (1)

Department of Psychiatry, The University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath